{
    "code": "52027354",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027354",
    "time": "2022-12-16 04:00:27",
    "許可證字號": "衛部藥輸字第027354號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/12\/20",
    "發證日期": "106\/12\/20",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202735403",
    "中文品名": "&quot;卡比&quot;利挫德注射劑",
    "英文品名": "Linezolid 2mg\/ml Solution for Infusion &quot;Kabi&quot;",
    "適應症": "「治療由下列感受性菌株感染的患者：Vancomycin抗藥性的Enterococcus faecium感染，包括併發菌血症的病例。醫院感染的肺炎，由Staphylococcus aureus（對methicillin有感受性和對methicillin有抗藥性的菌株）或Streptococcus pneumoniae（對penicillin有感受性的菌株）所引起。複雜性皮膚和皮膚構造感染，包括糖尿病足感染，無併發骨髓炎，由Staphylococcus aureus（對methicillin有感受性和對methicillin有抗藥性的菌株）、Streptococcus pyogenes或Streptococcus agalactiae所引起。非複雜性皮膚和皮膚構造感染，由Staphylococcus aureus（僅限於對methicillin有感受性的菌株）或Streptococcus pyogenes所引起。社區感染的肺炎，由Streptococcus pneumoniae（僅限於對penicillin有感受性的菌株），包括併發菌血症的病例，或Staphylococcus aureus（僅限於對methicillin有感受性的菌株）所引起」。",
    "劑型": "270注射劑",
    "包裝": "300毫升 (freeflex bag)塑膠軟袋裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "監視期滿學名藥",
    "監視期限": "",
    "主成分略述": "LINEZOLID",
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "6201179728  台灣費森尤斯卡比股份有限公司",
    "申請商地址": "台北市大安區仁愛路三段30號5樓32號5樓",
    "主製造廠": [
        {
            "製造廠名稱": "FNO0005000  FRESENIUS KABI NORGE AS",
            "製造廠廠址": "SVINESUNDSVEIEN 80, HALDEN, NO-1788, NORWAY",
            "製造廠公司地址": "",
            "製造廠國別": "NORWAY",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200042000",
            "成分名稱": "LINEZOLID",
            "含量描述": "",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "產品外觀-107-03-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027354&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "中文仿單稿_Linezolid_FKT-027354-0522_Final-111-05-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027354&Seq=002&Type=9"
        },
        {
            "title": "18812018_外箱-107-03-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027354&Seq=003&Type=8"
        },
        {
            "title": "17812026_軟袋外包裝(overwrap)-107-03-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027354&Seq=002&Type=8"
        },
        {
            "title": "16812018_軟袋-107-03-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027354&Seq=001&Type=8"
        }
    ]
}